14.30

0.56% +0.08

Alto Neuroscience Inc (ANRO)

Overview News Price History Discussions Forecast

Alto Neuroscience Inc stock is currently priced at $14.30, with a 24-hour trading volume of 140.70K. It has seen a +0.56% increased in the last 24 hours and a -1.52% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $14.24 pivot point. If it approaches the $14.62 resistance level, significant changes may occur.

Previous Close:

$14.22

Open:

$14.2

24h Volume:

140.70K

Market Cap:

$384.44M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-8.10%

1M Performance:

-1.52%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$13.80

$14.77

52W Range:

$12.78

$24.00

Alto Neuroscience Inc Stock (ANRO) Company Profile

Name

Alto Neuroscience Inc

Sector

Healthcare (1215)

Industry

Biotechnology (700)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ANRO's Discussions on Twitter

Alto Neuroscience Inc Stock (ANRO) Latest News

Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In Neuropsychiatry Landscape

Benzinga

Alto Neuroscience (ANRO): Strong Industry, Solid Earnings Estimate Revisions

Zacks Investment Research

Alto Neuroscience Inc Stock (ANRO) Financials Data

There is no financial data for Alto Neuroscience Inc (ANRO). Check out other stocks for more information.

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.